Johnson & Johnson MedTech CEO Tim Schmid said the company is entering its next phase of growth with a sharper focus on ...

MMI announced that the first patient has been enrolled in the PRECISE clinical study, a U.S. multi-center trial evaluating ...

Abbott (NYSE: ABT) shares dipped before hours today on third-quarter results that fell short of the consensus Wall Street ...

Anteris Technologies (Nasdaq:AVR) announced today that it received clearance to begin a trial of its DurAVR heart valve ...

Globus Medical launched the Anthem Elbow Fracture System, a plating system designed to help surgeons manage a wide range of ...

Now, in an SEC filing dated Oct. 14, Dentsply said the SEC concluded its investigation and doesn’t recommend any enforcement ...

Adagio Medical announced today that it entered into a securities purchase agreement worth up to $50 million in proceeds.

Stereotaxis (NYSE:STXS) announced today that it received CE mark for its Synchrony system while also submitting it to the FDA.

Johnson & Johnson (NYSE: JNJ) announced today that it intends to separate its DePuy Synthes Orthopaedics business.

BVI announced today that the FDA approved its FineVision HP trifocal intraocular lens (IOL) for cataract surgery.

Avalus Ultra builds on 10 years of clinical experience and long-term durability from the original Avalus valve launched in ...